Comparative analysis of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in colorectal cancer and surrounding normal tissue

Neoplasma

Volumn 52, Issue 3, 2005, Pages 208-210

  Zimovjanova, M ^a   Sykora, V ^b   Novotny, J ^a   Gatek, J ^c   Petruzelka, L ^a   Holubec, L ^d   Pecen, L ^e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Atlas Hospital   (Czech Republic)

^d Hospital Plzen   (Czech Republic)

^e INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Colon cancer; Dihydropyrimidine dehydrogenase; Thymidine phosphorylase; Thymidylate synthase

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROPYRIMIDINE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME DEGRADATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; REAL TIME POLYMERASE CHAIN REACTION; RECTUM MUCOSA;

EID: 20144373626     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rates. J Clin Oncol 1992; 10: 896-903.
2. DE GRAMONT A, LOUVET C, ANDRE T, TOURNIGAND C, KRULIK M. A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of the regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs. Eur J Cancer 1998; 34: 619-626.
3. MAYER RJ. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer; by either route, it's all the same. J Clin Oncol 2001; 19: 4093-4096.
4. MIWA M, URA M, NISHIDA M, SAWADA N, ISHIKAWA T et al. Design of a Novel Oral Fluoropyrimidine Carbamate, Capecitabine, which Generates 5-Fluorouracil Selectively in Tumours by Enzmyes Concentrated in Human Liver and Cancer Tissue. Eur J Cancer 1998; 34: 1274-1281.
5. SCHÜLLER J, CASSIDY J, DUMONT E, RODS B, DURSTON S et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 2000; 45: 291-297.
6. SHOMORIK, SAKATANI T, GOTO A, MATSLTURAT, KIYONARIH, ITO H. Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: Role of p53 expression. Pathol Int 1999; 49: 491-499.
7. HABA A, MONDEN T, SEKIMOTO M. PynPase expression in human colon cancer. Cancer Lett 1998; 122: 85-92.
8. SAWADA N, ISHIKAWA T, SEKIGUCHI F. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 1999; 5: 2948-2953.
9. RICH TA, SHEPARD RC, MOSLEY ST. Four decades of continuing innovation with fluorouracil: Current and future approaches to fluorouracil chemoradiation therapy. J Clin Oncol 2004; 22: 2214-2232.
10. NISHINA T, HYODO I, MIYAIKE J, INABA T, SUZUKI S, SHIRATORI Y. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predicitve of the clinical response to 5-deoxy-5-fluorouridine. Eur J Cancer 2004; 40: 1566-1571.
11. VAN TRIEST B, PINEDO M, BLAAUWGEERS JLG, VAN DIEST PJ, SCHOENMAKERS S et al. Prognostic Role of Thymidylate Synthase. Clin Cancer Res 2000; 6: 1063-1072.
12. ODIN E, WETTERGREN Y, NILSSON S, WILLEN R, CARLOSSON G et al. Altered gene expression of folate enzymes in adjancent mucosa is associated with outcome of colorectal cancer patients. Clin Cancer Res 2003; 9: 6012-6019.